Concord Biotech (BOM:543960) Short-Term Capital Lease Obligation : ₹20 Mil (As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Concord Biotech Short-Term Capital Lease Obligation?

Concord Biotech's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was ₹20 Mil.

Concord Biotech's quarterly Short-Term Capital Lease Obligation declined from Sep. 2024 (₹18 Mil) to Dec. 2024 (₹0 Mil) but then increased from Dec. 2024 (₹0 Mil) to Mar. 2025 (₹20 Mil).

Concord Biotech's annual Short-Term Capital Lease Obligation increased from Mar. 2023 (₹1 Mil) to Mar. 2024 (₹16 Mil) and increased from Mar. 2024 (₹16 Mil) to Mar. 2025 (₹20 Mil).

Concord Biotech Short-Term Capital Lease Obligation Historical Data

The historical data trend for Concord Biotech's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Biotech Short-Term Capital Lease Obligation Chart

Concord Biotech Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

13.01

15.96

1.47

16.21

19.58

Concord Biotech Quarterly Data
	Mar20	Mar21	Mar22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial									16.21	-	18.17	-	19.58

Concord Biotech Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Concord Biotech Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Concord Biotech's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Concord Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Concord Biotech Ltd (BOM:543960) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

CONCORDBIO:India

Address

Iscon Cross Road, S.G. Highway, B-1601-1602, B-Wing, Mondeal Heights, Ahmedabad, GJ, IND, 380015

Website

https://www.concordbiotech.com

Concord Biotech Ltd is a research and development-driven biopharma company that manufactures Active Pharmaceutical Ingredients (API) through fermentation and semi-synthetic process and finished formulations. It is mainly engaged in the business of manufacturing and trading in pharmaceutical products.

Concord Biotech Headlines

No Headlines